openPR Logo
Press release

Active Implantable Medical Devices Market by Product Type (Pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices, Neurostimulator, Drug Infusion Pump, Implantable Loop Recorder, Cochlear Implant, and others)

07-09-2018 03:43 PM CET | Health & Medicine

Press release from: CMI - Market Research

Active Implantable Medical Devices Market by Product Type

The Global Active Implantable Medical Devices Market by product type (pacemaker, implantable cardioverter defibrillator, cardiac resynchronization therapy devices, neurostimulator, drug infusion pump, implantable loop recorder, cochlear implant, and others), and region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 16,721.2 million in 2016 and is projected to exhibit a CAGR of 5.4% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Advancements in technology in active implantable medical devices such as MRI compatible pacemakers and cochlear implants with smartphone connectivity are being developed by key players in the market, which is expected to be a major driving factor propelling demand for active implantable medical devices over the forecast period.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1126

Manufacturers are focusing on upgrading the available implantable medical devices as well as developing new devices for various acute conditions related to diseases such as cardiovascular and neurological. In 2016, Medtronic Plc. was the first company to receive the U.S. Food & Drug Administration (FDA) approval for leadless pacemaker, Micra. Micra transcatheter pacing system (TPS) is 93% smaller than conventional pacemakers and Micra is directly placed in heart for monitoring the heart rate. Furthermore, in 2016, Boston Scientific Corporation was successful in receiving approval for its EMBLEM MRI subcutaneous implantable cardioverter defibrillator (ICD) system. Biotronik received approval for its leadless ICD system, which is first of its kind, in the U.S. in July 2017. Moreover, in 2016, Medtronic plc was the first company to receive FDA approval for magnetic resonance imaging (MRI) conditional cardiac resynchronization therapy devices (CRT-D), and was also successful in receiving approval from FDA for MR-Conditional Quadripolar CRT-P in May 2017. In 2016, St. Jude Medical launched its first commercial implants of dorsal root ganglion (DRG) stimulation therapy for management of chronic intractable pain in the U.S. Furthermore, Cochlear Limited launched iPhone compatible cochlear implant in July 2017. Abbott announced European CE mark approval for world’s first smartphone compatible Confirm Rx insertable cardiac monitor in October 2017.

Browse 30 Market Data Tables and 56 Figures spread through 197 Pages and in-depth TOC on Active Implantable Medical Devices Market by Product Type (pacemaker, implantable cardioverter defibrillator, cardiac resynchronization therapy devices, neurostimulator, drug infusion pump, implantable loop recorder, cochlear implant, and others), and Region (North America, Latin America, Europe, Asia-Pacific, the Middle East, and, Africa) - Global Forecast to 2025

Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1126

Key Takeaways of the Active Implantable Medical Devices Market:

Strong competition in the market spurs the demand for continuous development from supply as well as demand side as manufacturers thrive to stay competitive in the market and customers remain on the lookout for the alternatives boosting the development rate in active implantable medical devices market driving growth of the global active implantable medical devices market

Implantable Neurostimulators product type segment is expected to show significant growth owing to increasing application in management of chronic pain diseases

Asia Pacific region is expected to show significant growth owing to multiple product launches by major players such as launch of Edora pacemakers by Biotronik in Japan in 2017

According to WHO, 31% (about 17.7 million) of all global deaths were due to cardiovascular diseases (CVDs) and this number is expected to grow further as aging population, which are more prone to CVDs is growing. Growing prevalence of cardiovascular diseases, which can be monitored or treated by devices such as pacemakers and ICDs, is expected to be the major factors driving growth of the global active implantable medical devices market over the forecast period

Major players operating in the active implantable medical devices market include Cochlear Limited, Boston Scientific Corporation, Medtronic Plc, LivaNova Plc, Abbott Laboratories, Sonova Holding AG, William Demant holding A/S, Nurotron Biotechnology Co., Ltd., and Med-EL

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1126

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154
#3200

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Active Implantable Medical Devices Market by Product Type (Pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices, Neurostimulator, Drug Infusion Pump, Implantable Loop Recorder, Cochlear Implant, and others) here

News-ID: 1116351 • Views: 163

More Releases from CMI - Market Research

Dental Braces Market - Industry Insights, Size, Share, Growth, Analysis, Trends …
Dental braces are commonly used in orthodontic treatment to improve an individual’s orofacial appearance. Malocclusions (tooth overcrowding or crooked teeth), overbites, deep bites, cross bites, under bites, and incorrect jaw positions are some of the conditions that affect the orofacial appearance and other orthodontic problems. Malocclusions often lead to lack of confidence in a person. Increasing number of cases of malocclusions, jaw disease, jaw pain, tooth decay, and tooth loss
Colon and Rectal Cancer Drugs Market – Industry Size, Growth, outlook and Anal …
Colon and rectal cancer are often grouped together, as they have many common features. Rate of colorectal cancer is increasing among the millennials in the U.S. The American Cancer Society (ACS) estimates that there will be around 97,220 new cases of colon cancer and around 43,030 new cases of rectal cancer registered in the U.S. in 2018. Moreover, owing to increasing risk of colorectal cancer, in May 2018, ACS updated
Clostridium Difficile Infection Treatment Market Growth, Size, Trends and Analys …
Clostridium difficile, which produces gram-positive bacterium, is an anaerobic toxin that gets transmitted through fecal-oral route. Clostridium difficile infection occurs during antibiotic treatment or can be caused due to healthcare associated infection with clinical manifestation ranging from asymptomatic infection to watery diarrhea or serious intestinal condition such as colitis and colonic perforation. This infection can be diagnosed by enzyme immunoassays for toxins or Clostridium difficile glutamate dehydrogenase (GDH) and nucleic
Cervical Cancer Drugs Market - Size, Share, Growth | Trend and Analysis, 2018-20 …
Cervical cancer develops in women’s cervix, and mainly affects sexually active women aged between 30 and 45. Cervical cancer often shows no symptoms in early stages. However, the death rate of cervical cancer can be significantly reduced with use of Pap test (Papanicolaou test): a screening procedure which can detect the changes in the cervix before the cancer develops. There are different types of cervical cancer, out of which two

All 5 Releases


More Releases for Implantable

Active Implantable Medical Devices Market (Implantable Cardioverter Defibrillato …
Global Active Implantable Medical Devices Market 2018 report includes Active Implantable Medical Devices Market Size, Revenue, market Share, Active Implantable Medical Devices industry volume, market Trends, Active Implantable Medical Devices Growth aspects. A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report. It shows manufacturing capacity, Active Implantable Medical Devices Price during the Forecast period from 2018 to 2025. For In depth Information Get
Implantable Ports Market - Competition Framework 2017-2025
Global Implantable Ports Market: Overview Implantable ports, which are long, narrow, soft, and thin plastic tubes with a rubber disc at the end, are frequently inserted into chemotherapy patients in order to administrate drugs to individuals. Also called as portacaths or subcutaneous, the diameter of implantable ports ranges from 2.5 cm to 4 cm and are highly useful for patients receiving treatment into a vein. Blood transfusions, chemotherapy, intravenous (IV) fluids,
Implantable Ports Market Sharp Rise over 2025
Global Implantable Ports Market: Overview Implantable ports, which are long, narrow, soft, and thin plastic tubes with a rubber disc at the end, are frequently inserted into chemotherapy patients in order to administrate drugs to individuals. Also called as portacaths or subcutaneous, the diameter of implantable ports ranges from 2.5 cm to 4 cm and are highly useful for patients receiving treatment into a vein. Blood transfusions, chemotherapy, intravenous (IV) fluids,
Implantable Medical Devices Market: A comprehensive survey
The global market for implantable medical devices market is experiencing an increased demand due to rampant technological advancements. The market is highly consolidated as the top four players account for a little over 50% of the market share making it difficult for new players to enter the market. Moreover, the research excellence attained by these established players overpowers the ability of other small and medium sized players to innovate and
Implantable Cardioverter Defibrillators Contribute Largest Revenue to the Global …
According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of
Global Implantable Ports Market 2017-2021
MarketResearchReports.Biz presents this most up-to-date research on "Global Implantable Ports Market 2017-2021" Description Implantable ports are thin, soft plastic tubes with a rubber disc at the end. Implantable ports are also called as subcutaneous ports or portacaths. They are most commonly inserted in patients undergoing chemotherapy. These ports are used to administer drugs to individuals. The diameter of the port ranges from 2.5 cm to 4 cm. Based on the product type,